“gilead-sciences” Archives

in
Entry Author Date Location
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More 10/02/20 National
Galecto Picks Up $64M as Plans for Fibrosis Clinical Trials Move Forward 09/25/20 Europe
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Seattle Genetics Lands $1.72B From Merck in Pair of Cancer Drug Deals 09/14/20 Seattle
Gilead Adds “Cornerstone” Cancer Drug in $21B Immunomedics Buyout 09/14/20 San Francisco
AbbVie Strikes Deal for I-Mab Drug With a Potential Edge in CD47 Chase 09/04/20 National
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More 09/04/20 National
Gilead Sciences Places $120M Bet on a Jounce Therapeutics Cancer Drug 09/01/20 San Francisco
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
FDA Adds Plasma as 2nd COVID-19 Treatment Under Emergency Guidelines 08/24/20 National
Bio Roundup: J&J Buyout, BioMarin Rebuffed, Poseida on Hold & More 08/21/20 National
Tango Therapeutics Adds $175M, Deal Turns Partner Gilead Into Investor 08/17/20 Boston
MorphoSys, Incyte Get Early FDA Nod for Antibody Alternative to CAR-T 08/03/20 Europe
Kymera Therapeutics Unveils IPO Pitch for Protein Degradation 07/31/20 Boston
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
Gilead Gets Another CAR-T Approval, This Time for Mantle Cell Lymphoma 07/24/20 San Francisco
Bio Roundup: Jazz Drug OK’d, Gilead’s Bet, Moderna Patent Decision & More 07/24/20 National
Gilead Sciences Splashes Out $300M for Tizona Stake & Option to Acquire 07/21/20 San Francisco
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
Bio Roundup: Blackstone’s Billions, Biogen Finishes Filing, Novavax at “Warp Speed” & More 07/10/20 National
VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs 07/09/20 San Diego
On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO 07/06/20 San Francisco
Moderna: Speed of COVID 19 Vaccine Hinges On Enrolling Right Patients 07/02/20 National
FDA Says “No” to Intercept Pharma’s NASH Drug, Asks for More Data 06/29/20 New York
Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More 06/26/20 National
Gilead Grabs Option to Acquire Pionyr & Its Clinic-Bound Immunotherapies 06/23/20 San Francisco
Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better 06/19/20 Raleigh Durham
Orca Bio Surfaces With $192M and Recipes for “Custom” Cell Therapies 06/17/20 San Francisco
FDA Reverses Authorization for Use of Antimalarials to Treat COVID-19 06/15/20 National
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Page 1 of 14 next page »